SCHEMBL22762511

SCHEMBL22762511

CS(=O)(=O)N1CCC(C(=O)Nc2ccc(-c3cncc(C4CC4)n3)cn2)(c2nccc(N[S+]([O-])C3CC3)n2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTPS1 P17812 14/20 0.42
▸ TDO2 P48775 1/20 0.34
▸ WNT1 P04628 2/20 0.33
▸ GSK3B P49841 2/20 0.33
▸ DYRK1A Q13627 2/20 0.33
▸ DYRK3 O43781 1/20 0.32
▸ CLK1 P49759 1/20 0.32
▸ CLK2 P49760 1/20 0.32
▸ CLK3 P49761 1/20 0.32
▸ CDK5 Q00535 1/20 0.32
▸ CDK5R1 Q15078 1/20 0.32
▸ DYRK2 Q92630 1/20 0.32
▸ CLK4 Q9HAZ1 1/20 0.32
▸ DYRK4 Q9NR20 1/20 0.32
▸ DYRK1B Q9Y463 1/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ KDR P35968 1/20 0.30
▸ ETV6 P41212 1/20 0.30
▸ PIK3R1 P27986 1/20 0.30
▸ PIK3CA P42336 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22762269 0.86 CTPS1 (0.44) CTPS1GSK3BDYRK1ACLK2CLK3
SCHEMBL30528887 0.86 CTPS1 (0.54) CTPS1CTPS2
SCHEMBL22749234 0.79 CTPS1 (0.54) CTPS1
SCHEMBL29565873 0.79 CTPS1 (0.54) CTPS1
SCHEMBL22758532 0.76 CTPS1 (0.60) CTPS1
SCHEMBL22762663 0.75 CTPS1 (0.63) CTPS1
SCHEMBL22762268 0.73 CTPS1 (0.58) CTPS1CTPS2
Hydrochloric Acid SCHEMBL29565805 0.73 CTPS1 (0.58) CTPS1CTPS2
SCHEMBL30528738 0.70 CTPS1 (0.64) CTPS1
SCHEMBL22758546 0.68 CTPS1 (0.62) CTPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020245665-A1 N-(4-(5-CHLOROPYRIDIN-3-YL)PHENYL)-2-(2-(CYCLOPROPANESULFONAMIDO)PYRIMIDIN-4-YL) BUTANAMIDE DERIVATIVES AND RELATED COMPOUNDS AS HUMAN CTPS1 INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES STEP PHARMA S.A.S. (FR) 2020-12-10 — — WO disclosed
Send feedback